OpenDBM is an open-source platform that democratizes access to AiCure’s scientifically validated digital biomarker algorithms so researchers can apply them to their own datasets. This transparency encourages industry and academic collaboration, helping to validate digital biomarkers as a legitimate means to understanding disease and patient behavior.